BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $703,059 | -17.5% | 18,629 | -0.5% | 0.10% | -8.8% |
| Q2 2023 | $852,610 | -3.0% | 18,714 | -13.7% | 0.11% | -0.9% |
| Q1 2023 | $879,098 | -39.5% | 21,674 | +15.7% | 0.12% | -45.0% |
| Q1 2022 | $1,452,000 | -10.0% | 18,732 | -0.4% | 0.21% | -0.9% |
| Q4 2021 | $1,614,000 | +7.1% | 18,802 | +0.4% | 0.21% | +2.4% |
| Q3 2021 | $1,507,000 | 0.0% | 18,733 | +0.1% | 0.21% | -1.0% |
| Q2 2021 | $1,507,000 | -4.6% | 18,716 | 0.0% | 0.21% | -11.5% |
| Q1 2021 | $1,579,000 | +5.0% | 18,716 | -0.2% | 0.24% | +0.9% |
| Q4 2020 | $1,504,000 | -0.1% | 18,745 | +0.1% | 0.23% | -0.4% |
| Q3 2020 | $1,505,000 | -9.4% | 18,720 | -3.0% | 0.23% | +2.6% |
| Q2 2020 | $1,662,000 | +6.1% | 19,302 | 0.0% | 0.23% | -9.2% |
| Q1 2020 | $1,567,000 | -2.9% | 19,302 | 0.0% | 0.25% | +42.6% |
| Q4 2019 | $1,614,000 | +0.2% | 19,302 | +4.9% | 0.18% | -6.9% |
| Q3 2019 | $1,610,000 | +6.8% | 18,402 | 0.0% | 0.19% | -2.1% |
| Q2 2019 | $1,507,000 | +0.7% | 18,402 | 0.0% | 0.19% | +1.0% |
| Q1 2019 | $1,496,000 | +10.1% | 18,402 | 0.0% | 0.19% | -7.7% |
| Q4 2018 | $1,359,000 | -4.2% | 18,402 | 0.0% | 0.21% | +2.0% |
| Q3 2018 | $1,419,000 | +4.4% | 18,402 | 0.0% | 0.20% | -1.5% |
| Q2 2018 | $1,359,000 | +13.5% | 18,402 | 0.0% | 0.21% | +7.9% |
| Q1 2018 | $1,197,000 | +0.6% | 18,402 | 0.0% | 0.19% | +7.9% |
| Q4 2017 | $1,190,000 | +3.0% | 18,402 | 0.0% | 0.18% | -1.1% |
| Q3 2017 | $1,155,000 | +3.7% | 18,402 | 0.0% | 0.18% | +1.1% |
| Q2 2017 | $1,114,000 | +17.6% | 18,402 | +0.8% | 0.18% | +18.0% |
| Q1 2017 | $947,000 | +16.9% | 18,262 | 0.0% | 0.15% | +22.0% |
| Q4 2016 | $810,000 | -9.3% | 18,262 | -2.7% | 0.12% | -8.9% |
| Q3 2016 | $893,000 | +5.2% | 18,765 | 0.0% | 0.14% | +11.6% |
| Q2 2016 | $849,000 | +10.1% | 18,765 | 0.0% | 0.12% | +13.1% |
| Q1 2016 | $771,000 | +5.2% | 18,765 | -2.3% | 0.11% | +2.9% |
| Q4 2015 | $733,000 | +16.2% | 19,215 | 0.0% | 0.10% | -1.9% |
| Q3 2015 | $631,000 | -53.1% | 19,215 | 0.0% | 0.11% | -50.2% |
| Q2 2015 | $1,344,000 | +2.1% | 19,215 | 0.0% | 0.21% | +1.9% |
| Q1 2015 | $1,316,000 | -12.6% | 19,215 | -6.4% | 0.21% | +11.8% |
| Q4 2014 | $1,505,000 | +2.1% | 20,533 | 0.0% | 0.19% | -5.1% |
| Q3 2014 | $1,474,000 | +1.2% | 20,533 | +1.9% | 0.20% | +1.5% |
| Q2 2014 | $1,456,000 | – | 20,144 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |